Includes innovative new Maldi O-Tof mass spectrometer for protein identification, enhanced security Labworks Lims, and economical Elan DRC-e ICP-MS
PerkinElmer is exhibiting 12 significant new products at the annual Pittsburgh Conference (Pittcon) in Orlando, USA.
Chief among the new products to be shown is the Protof 2000 Maldi O-Tof (matrix-assisted laser desorption ionisation orthogonal time-of-flight) mass spectrometer that features next-generation Maldi-Tof technology for the identification and characterisation of proteins.
Protof 2000 represents a substantial leap forward in mass accuracy and stability by applying a new technology that decouples the Maldi and Tof components.
This approach addresses limitations associated with traditional linear Maldi-Tof designs. The new Protof instrument integrates a unique combination of hardware and software that can accurately 'fingerprint' proteins involved in the functioning of organs and biochemical processes in the human body.
High-speed, accurate analysis of proteins is considered essential for the research and development of powerful new drugs capable of combating a wide range of illnesses and medical conditions.
"Our new Protof 2000 Maldi O-Tof mass spectrometer makes a powerful new tool for protein research accessible to the life science community.
It also demonstrates the results of strategic partnering with other innovators such as MDS Sciex as well as the synergies growing out of our partnering across our merged analytical instruments and life sciences businesses," said Peter Coggins, president of PerkinElmer Life and Analytical Sciences.
"Protof is designed to help researchers significantly expand the speed and accuracy of their work, driving drug discovery to improve some of the most challenging areas of human health." In keeping with the recent growth of pharmaceutical and life science audiences at Pittcon, Coggins noted that PerkinElmer's portfolio of new products at the conference represents a balance of informatics software and instruments for chemical analysis, drug discovery and pharmaceutical QA/QC.
"As PerkinElmer aggressively expands its integrated solutions for the life sciences, we also continue to develop innovative new products for chemical and environmental analyses," Coggins continued.
"For instance, we have introduced the affordable Elan DRC-e ICP mass spectrometer, which includes our patented interference eliminating dynamic reaction cell technology.
This is a highly sensitive instrument that is exceptionally easy to use and requires minimal maintenance." Coggins also underscored the importance of a new comprehensive PerkinElmer services initiative called OneSource that will help laboratories validate instruments, qualify and train operators and maintain hardware. "OneSource addresses a growing burden in many labs and frees them to focus on their core competencies while reducing their costs and improving uptime," Coggins concluded.
Other new products to be highlighted in the PerkinElmer booths include: Labworks Enhanced Security (ES) Lims, which supports electronic records and signatures, now includes a robust capability for language internationalisation.
PerkinElmer is also partnering with other solutions providers to deliver a pharmaceutical QA/QC Lims in 2003.
The new near-infrared Tablet Autosampler - coupled with version 2.0 of PerkinElmer's 21 CFR Part 11-compliant Spectrum AssureID software high-sensitivity imaging system - delivers fast, non-destructive whole tablet chemical composition assays, enabling pharmaceutical manufacturing organisations to reduce testing time, inventory and testing costs.
The Spectrum Spotlight 350 FT-NIR (Fourier-Transform Near-Infrared) imaging system rapidly provides pharmaceutical development organisations with information about micro-scale chemical variations for faster problem solving, shorter time-to-market for new formulations, and reduced rework costs.
HyperDSC, a breakthrough thermal analysis method for material characterisation only available on the Diamond differential scanning calorimeter (DSC), delivers superb sensitivity and new insights into materials processes that cannot be obtained with conventional DSC methods.
Optima 4300V, a new version of the best-selling inductively-coupled plasma (ICP) spectrometer that provides high throughput and accurate results on difficult matrices such as oils/organics, precious metals and geochemical samples.
The innovative design of the Optima 4300V also significantly reduces maintenance and operating costs. Proxcision, a robust instrument for automated, high precision excision of protein candidates from 2-D protein gels and bands from 1-D protein gels.
Tofprep Maldi spotting system, a high throughput Maldi-Tof spotting instrument capable of spotting targets for use with various commercially available Maldi-Tof systems.
To further speed often time consuming and tedious tasks of plate preparation and assay development, the FlexDrop EX series innovative reagent dispensers provide extra capacity and fully automated operation with integrated stackers for unattended feeding of microplates.
FlexDrop offers industry-leading performance for dispensing up to four reagents in the industry's widest dynamic range - from 200nl to 2.0ml into 96-, 384- and 1536-well microplates.
MiniTrak liquid handling models with increased plate capacity, higher throughput and new software tools for assay development.
Each MiniTrak features PerkinElmer's Stack Doubler module, providing compact, high capacity microplate and pipette tip storage as well as a unique 20-inch module that allows for more reagent positions.
SPCM-AQ4C photon detector - the latest addition to PerkinElmer's line of biomedical imaging technologies, which includes channel photomultipliers (CPMs) and charged coupled devices (CCDs).
The AQ4C Single Photon Counting Module (SPCM) is the industry's only four-channel photon counting card capable of detecting single photons over a wavelength range of 400nm to 1100nm.
The four-channel array enables researchers to test four wavelengths (or colours) at a time, not just one, saving time and improving accuracy in drug discovery and genomic research.
